Module 2: Disease-Modifying SMA Therapies in Late Adolescents and Adults
Primary Audience:
This activity is intended to meet the educational needs of healthcare professionals involved in the care of patients with SMA.
This module will discuss clinical trial data and updates on disease-modifying SMA therapies for older adolescents and adults.
Brett McCray, MD, PhD
Assistant Professor of Neurology
Department of Neurology
Johns Hopkins Hospital
Baltimore, MD
Brett McCray is an assistant professor in neurology whose clinical and research interest is furthering the understanding and treatment of peripheral neuropathy, particularly inherited forms of peripheral neuropathy such as Charcot-Marie-Tooth (CMT) disease.
1.
Apply recently published clinical data to therapeutic treatment of adults with SMA.
